Buspirone attenuates neuropathic pain and related depression following sciatic nerve injury in mice: Role of opioid receptors
Behavioural Brain Research · 2027
DOI: 10.1016/j.bbr.2026.116456 ↗Kurz gefasst
Fachartikel in der Zeitschrift Behavioural Brain Research, 2027. Verfasst von Behnam Ghorbanzadeh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran. Electronic address: Ghorbanzadeh.b@dums.ac.ir. Hauptthemen laut MEDLINE: Neuralgia, Buspirone, Depression, Receptors, Opioid. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Dezful University of Medical Sciences.
Themen: Depression
Abstract (Originalsprache)
Patients with neuropathic pain also experience depression. Although they are treated with various therapies, the effectiveness of these medications is unclear. In the present study, the effect of buspirone on allodynia and depressive-like behavior caused by chronic constriction injury (CCI) of the sciatic nerve, as well as the role of opioid pathways, was investigated. Our findings showed that acute and sub-chronic administration of buspirone (0.3-10 mg/kg) attenuated the mechanical and cold allodynia induced by CCI. In addition, a moderate dose of buspirone (1 mg/kg), but not a high dose (10 mg/kg), reduced the depressive-like behavior induced by CCI. Furthermore, pretreatment with naloxone attenuated the effects of buspirone, whereas co-administration with an ineffective dose of morphine potentiated its action. Also, hippocampal μ-opioid receptor mRNA was decreased, whereas κ-opioid receptor mRNA was increased in CCI mice 14 days after surgery. However, repeated buspirone in CCI-mice mitigated the observed alteration in opioid receptors mRNA expression. In addition, unlike morphine, buspirone did not produce tolerance or withdrawal symptoms following repeated administration. Collectively, these data provide evidence that buspirone can effectively alleviate neuropathic pain and exerts antidepressant-like benefits, potentially through modulation of opioid receptors. Moreover, the effects of buspirone may also be associated with changes in mRNA expression of μ-and κ-opioid receptors in the hippocampus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran. Electronic address: Ghorbanzadeh.b@dums.ac.ir.
- Student Research Committee, Dezful University of Medical Sciences, Dezful, Iran.
- Infectious and Tropical Diseases Research Center, Dezful University of Medical Sciences, Dezful, Iran; Department of Genetics and Molecular Biology, Dezful University of Medical Sciences, Dezful, Iran.
- Department of Pharmacology, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran.
Förderung
- Dezful University of Medical Sciences
Zitieren
APA
Ghorbanzadeh, B., Foroughinia, A., Notash, R., Mashayekhi, A., Alboghobeish, S., & Gholamiyan, K. (2027). Buspirone attenuates neuropathic pain and related depression following sciatic nerve injury in mice: Role of opioid receptors. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2026.116456
Vancouver
Ghorbanzadeh B, Foroughinia A, Notash R, Mashayekhi A, Alboghobeish S, Gholamiyan K. Buspirone attenuates neuropathic pain and related depression following sciatic nerve injury in mice: Role of opioid receptors. Behavioural Brain Research. 2027. doi:10.1016/j.bbr.2026.116456
BibTeX
@article{Ghorbanzadeh2027,
author = {Ghorbanzadeh, Behnam and Foroughinia, Ali and Notash, Reza and Mashayekhi, Amir and Alboghobeish, Soheila and Gholamiyan, Kosar},
title = {Buspirone attenuates neuropathic pain and related depression following sciatic nerve injury in mice: Role of opioid receptors},
journal = {Behavioural Brain Research},
year = {2027},
doi = {10.1016/j.bbr.2026.116456}
}
EUVIMED